InSys Says Board Acted On Compliance Issues With Narcotic
Attorneys for the directors of drugmaker InSys Therapeutics Inc. told a Delaware state court judge Tuesday that a shareholder derivative suit should be tossed because the board took steps to bolster...To view the full article, register now.
Already a subscriber? Click here to view full article